Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "No defined host molecular target" refers to a classification for drugs that do not interact with a specific, discrete biological molecule such as a receptor, enzyme, or ion channel to produce their therapeutic effect (DrugBank, 2024). This category includes agents that act through non-specific physical or chemical means, such as antacids (e.g., Aluminum hydroxide) which neutralize gastric acid via a simple chemical reaction, or osmotic agents (e.g., Mannitol) that alter fluid balance through physical pressure (ChEMBL, 2024). Additionally, this label is applied to drugs where the specific host target remains unknown or uncharacterized despite established clinical use (NCBI, 2023). Because these substances lack a specific binding site, they do not follow traditional lock-and-key pharmacodynamics and often require higher molar concentrations to be effective compared to targeted small molecules (StatPearls, 2023). This designation is critical for researchers and biotech analysts to identify compounds that fall outside the paradigm of target-based drug discovery.
Drugs in this category typically act through non-specific physical or chemical interactions, such as pH neutralization, osmotic effects, or adsorption, rather than binding to a specific protein or receptor.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No defined host molecular target.